RTO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Rentokil Initial plc and Encourages Investors to Contact the Firm!

Core Insights - Rentokil Initial plc expects full-year adjusted pretax profit to be approximately £700 million, down from £766 million the previous year, due to weaker sales in North America [2] - The company plans to cut an undisclosed number of jobs in its U.S. workforce to address cost overruns [2] - Following this announcement, Rentokil's American depositary receipt (ADR) price fell by $6.64, or 21.04%, closing at $24.95 on September 11, 2024 [2] Investigation Details - Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Rentokil securities [1] - Investors are encouraged to provide information related to the investigation [3] Legal Representation - The firm operates on a contingency fee basis, meaning they will only seek reimbursement for expenses and fees if successful [4] - Bronstein, Gewirtz & Grossman, LLC is recognized for representing investors in securities fraud class actions and has recovered significant amounts for investors [5]